We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+3.4%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$1.43T
AUM Growth
+$48.2B
Cap. Flow
+$31.6B
Cap. Flow %
2.22%
Top 10 Hldgs %
21.91%
Holding
8,265
New
347
Increased
3,539
Reduced
3,177
Closed
287

Sector Composition

Rank Sector Weight
1 Technology 22.55%
2 Financials 11.55%
3 Consumer Discretionary 9.73%
4 Healthcare 8.08%
5 Communication Services 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NACP icon
7026
Impact Shares NAACP Minority Empowerment ETF
NACP
$74.4M
$1.27K ﹤0.01%
31
-1
-3% -$42
CTXR icon
7027
Citius Pharmaceuticals
CTXR
$15.6M
$1.27K ﹤0.01%
318
+258
+430% +$1.74K
STIM icon
7028
Neuronetics
STIM
$138M
$1.27K ﹤0.01%
790
CEW
7029
WisdomTree Emerging Currency Strategy Fund
CEW
$15.8M
$1.27K ﹤0.01%
75
+9
+14% +$163
APTO
7030
DELISTED
Aptose Biosciences, Inc.
APTO
$1.24K ﹤0.01%
183
-862
-82% -$7.86K
ORBS
7031
Eightco Holdings
ORBS
$234M
$1.24K ﹤0.01%
564
+556
+6,950% +$1.07K
SDEV
7032
Stablecoin Development Corp
SDEV
$58M
$1.23K ﹤0.01%
408
+307
+304% +$970
ELTX icon
7033
Elicio Therapeutics
ELTX
$73.5M
$1.17K ﹤0.01%
230
-10
-4% -$49
ICU icon
7034
SeaStar Medical
ICU
$12.5M
$1.16K ﹤0.01%
60
-40
-40% -$1.14K
AXDX
7035
DELISTED
Accelerate Diagnostics
AXDX
$1.15K ﹤0.01%
957
-400
-29% -$664
SGRP
7036
DELISTED
SPAR Group
SGRP
$1.15K ﹤0.01%
590
GRABW icon
7037
Grab Holdings Warrant
GRABW
$601K
$1.14K ﹤0.01%
+2,800
New +$1.05K
AWH
7038
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$1.14K ﹤0.01%
1,616
SFYF icon
7039
SoFi Social 50 ETF
SFYF
$39.6M
$1.14K ﹤0.01%
26
+1
+4% +$41
MBOT icon
7040
Microbot Medical
MBOT
$116M
$1.13K ﹤0.01%
1,012
RULE icon
7041
Adaptive Core ETF
RULE
$15.4M
$1.12K ﹤0.01%
51
+1
+2% +$23
MRKR icon
7042
Marker Therapeutics
MRKR
$18.8M
$1.11K ﹤0.01%
358
-3,050
-89% -$10.8K
AIFA
7043
All In FutureTech Alliance Inc
AIFA
$10.3M
$1.11K ﹤0.01%
233
CSCI
7044
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$1.11K ﹤0.01%
+400
New +$1.3K
PVLA
7045
Palvella Therapeutics
PVLA
$1.99B
$1.09K ﹤0.01%
91
BRID icon
7046
Bridgford Foods
BRID
$57.6M
$1.08K ﹤0.01%
100
FTHM icon
7047
Fathom Holdings
FTHM
$26.4M
$1.07K ﹤0.01%
701
-1,000
-59% -$2.18K
HOFV
7048
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$1.07K ﹤0.01%
821
+627
+323% +$837
USAI icon
7049
Pacer American Energy Infrastructure ETF
USAI
$128M
$1.05K ﹤0.01%
+26
New +$1K
CAFX
7050
Congress Intermediate Bond ETF
CAFX
$319M
$1.05K ﹤0.01%
+43
New +$1.06K

Similar funds

Morgan Stanley's Q4 2024 Portfolio in Review

As of Q4 2024, Morgan Stanley held 8,265 positions worth $1.43T, up 3.5% from $1.38T the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Morgan Stanley's Q4 2024 filing shows 347 new, 3,539 increased, 3,177 reduced and 287 closed positions. Its largest new stake was Morgan Stanley Pathway Large Cap Equity ETF: 42,204,466 shares worth $2.03B. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $1.7B.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Morgan Stanley's largest Q4 2024 buy was Morgan Stanley Pathway Large Cap Equity ETF: 42,204,466 shares worth $2.03B.
  • Morgan Stanley added most to NVIDIA in Q4 2024, an estimated $2.75B increase.
  • Morgan Stanley's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.7B.
  • Morgan Stanley fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $259M.
  • Morgan Stanley's ten largest holdings make up 22% of its $1.43T portfolio in Q4 2024.
  • Morgan Stanley opened 347 new positions and closed 287 in Q4 2024.
  • Morgan Stanley's portfolio value rose 3.5% quarter-over-quarter to $1.43T.

Based on Morgan Stanley's 13F filing for Q4 2024, filed 14 Feb 2025.